Francisella tularensis is considered a Category A bioweapon due to the ease of transmission, the low infectious dose and high mortality associated with pneumonic tularemia, and the fact that it has been intensively studied and developed in bioweapons programs in several countries. Virtually nothing is known about virulence of aerosolized forms of the most likely bioweapon, F. tularensis subsp. tularensis. The focus of this research effort is to identify all the essential and virulence genes of F. tularensis subsp. tularensis through a genomics based approach. This will dramatically increase our understanding of F. tularensis pathogenesis, and facilitate the development of subunit and live-attenuated vaccines. First, we will utilize a genomics based technique termed GAMBIT to mutagenize every gene of F. tularensis subsp. tularensis, and then recombine them back onto the chromosome. This will allow for the identification of essential genes, which are potential therapeutic targets. The viable mutant bacteria will be combined in pools and inoculated via aerosol into mice, and those mutants that cannot survive within the host will be identified by a microarray-based technique. This technique will identify all genes important for F. tularensis virulence via the aerosol route, some of which may be potential subunit vaccine candidates. Next, the attenuated F. tularensis subsp. tularensis strains will be tested for markers of virulence: ability for intramacrophage survival and growth, resistance to antimicrobial compounds, and ability to invade nonphagocytic cells. This will allow for the identification and characterization of critical virulence determinants of F. tularensis. Finally, we will characterize the virulence regulatory factors identified by microarray analysis of transcription, including the transcriptional activator MgIA, which should illuminate virulence regulons within Francisella, allowing a better understanding of the molecular mechanisms of pathogenesis. Our research plan involves a multidisciplinary approach and high levels of integration with the other projects that compose this program project. Our combined expertise will propel our knowledge of F. tularensis pathogenesis and immunity and allow for the development of novel therapeutic and preventive measures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI057986-01A2
Application #
6912409
Study Section
Special Emphasis Panel (ZAI1-EC-M (J1))
Project Start
2005-04-01
Project End
2010-06-30
Budget Start
2005-04-01
Budget End
2006-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$226,366
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800189185
City
San Antonio
State
TX
Country
United States
Zip Code
78249
Nguyen, Jesse Q; Gilley, Ryan P; Zogaj, Xhavit et al. (2014) Lipidation of the FPI protein IglE contributes to Francisella tularensis ssp. novicida intramacrophage replication and virulence. Pathog Dis 72:10-8
Chu, Ping; Cunningham, Aimee L; Yu, Jieh-Juen et al. (2014) Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates. PLoS Pathog 10:e1004439
Tsai, Su-Yu; Segovia, Jesus A; Chang, Te-Hung et al. (2014) DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog 10:e1003848
Signarovitz, Aimee L; Ray, Heather J; Yu, Jieh-Juen et al. (2012) Mucosal immunization with live attenuated Francisella novicida U112ýýiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model. PLoS One 7:e47639
Arulanandam, Bernard P; Chetty, Senthilnath Lakshmana; Yu, Jieh-Juen et al. (2012) Francisella DnaK inhibits tissue-nonspecific alkaline phosphatase. J Biol Chem 287:37185-94
Hunter, Colleen; Rodriguez, Annette; Yu, Jieh-Juen et al. (2012) Comparison of bone marrow-derived and mucosal mast cells in controlling intramacrophage Francisella tularensis replication. Exp Biol Med (Maywood) 237:617-21
Segovia, Jesus; Sabbah, Ahmed; Mgbemena, Victoria et al. (2012) TLR2/MyD88/NF-?B pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One 7:e29695
Zogaj, Xhavit; Wyatt, Geoff C; Klose, Karl E (2012) Cyclic di-GMP stimulates biofilm formation and inhibits virulence of Francisella novicida. Infect Immun 80:4239-47
Rodriguez, Annette R; Yu, Jieh-Juen; Guentzel, M Neal et al. (2012) Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis. J Immunol 188:5604-11
Sanapala, Shilpa; Yu, Jieh-Juen; Murthy, Ashlesh K et al. (2012) Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ýýfopC vaccine strain. Infect Immun 80:2177-85

Showing the most recent 10 out of 49 publications